Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen

Photodermatol Photoimmunol Photomed. 1994 Oct;10(5):217-20.

Abstract

Thirty-eight patients with plaque-type psoriasis were enrolled in a double-blind psoralen plus ultraviolet A (PUVA) treatment study comparing the efficacy and side effects of 5-methoxypsoralen (5-MOP) and 8-methoxypsoralen (8-MOP). Patients treated with 8-MOP healed significantly faster than those on 5-MOP for 6 weeks of treatment, but there was no significant difference after 9 weeks. There was no significant difference in side effects between the two groups, but nausea tended to be more common in the 8-MOP group. One patient on 5-MOP had signs of toxic hepatitis. The importance for maximizing absorption of taking 5-MOP with food is stressed, and PUVA treatment should be given 3 h after intake of the drug.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • 5-Methoxypsoralen
  • Absorption
  • Adult
  • Aged
  • Chemical and Drug Induced Liver Injury / etiology
  • Double-Blind Method
  • Female
  • Food
  • Humans
  • Male
  • Methoxsalen / administration & dosage
  • Methoxsalen / adverse effects
  • Methoxsalen / analogs & derivatives*
  • Methoxsalen / pharmacokinetics
  • Methoxsalen / therapeutic use*
  • Middle Aged
  • Nausea / chemically induced
  • PUVA Therapy*
  • Psoriasis / drug therapy*
  • Time Factors

Substances

  • 5-Methoxypsoralen
  • Methoxsalen